3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow imiglucerase: new trials by email Literature Review of imiglucerase trials Research Report on imiglucerase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ Cerezyme® / Imiglucerase - Gaucher's Disease | Phase 4 | Completed | Sanofi | 12 | 2021-03-02 | 2025-09-15 |
| Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease Cerezyme - Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome | Phase 4 | Completed | Genzyme, a Sanofi Company | 95 | 2001-12-01 | 2015-04-03 |
| A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease. Cerezyme (imiglucerase for injection) - Gaucher Disease Type I, Cerebroside Lipidosis Syndrome | Phase 4 | Completed | Genzyme, a Sanofi Company | 40 | 1997-12-01 | 2015-03-05 |
Gaucher Disease (3)
Genzyme, a Sanofi Company (2) · Sanofi (1)
United States (2) · Brazil (1) · Canada (1) · China (1) · Italy (1) · Poland (1) · Spain (1) · United Kingdom (1)